Compliance of Antihypertensive Medication and Risk of Coronavirus Disease 2019: a Cohort Study Using Big Data from the Korean National Health Insurance Service.

Jaiyong Kim Dong Wook Kim Kwang Ill Kim Hong Bin Kim Jong Hun Kim Yong Gab Lee Kyeong Hyang Byeon Hae-Kwan Cheongnull null

Published in: Journal of Korean medical science (2020)

Renin-angiotensin system blockers or other antihypertensive medications do not increase the risk of COVID-19. Patients should not stop antihypertensive medications, including renin-angiotensin system blockers, because of concerns of COVID-19.

Keyphrases

coronavirus disease
health insurance
big data
blood pressure
sars cov
hypertensive patients
artificial intelligence
angiotensin converting enzyme
machine learning
affordable care act
healthcare
respiratory syndrome coronavirus
mental health
quality improvement
angiotensin ii
deep learning
emergency department